ELAC1, or elaC ribonuclease Z 1, is a protein that plays a crucial role in tRNA processing, specifically in the removal of 3' trailers from precursor tRNA molecules, a necessary step in the maturation of transfer RNAs. ELAC1 is characterized by its ribonuclease Z domain, which provides the endonucleolytic activity required for this precise cleavage.
The accurate and efficient processing of tRNA is fundamental to the translation of the genetic code into functional proteins. ELAC1 contributes to this process by recognizing and trimming the 3' ends of tRNA precursors to produce the mature 3' CCA end, which is essential for the attachment of amino acids during protein synthesis. The enzyme's specificity ensures that tRNAs are correctly processed, which is critical for maintaining the fidelity of protein translation. ELAC1 is localized in the nucleus, reflecting its role in tRNA maturation, which primarily occurs within this compartment. The activity of ELAC1 is particularly important because it helps maintain the pool of functional tRNAs within the cell, which in turn supports the overall protein synthesis machinery.Mutations or dysregulation of ELAC1 can lead to defects in tRNA processing, potentially resulting in a variety of cellular dysfunctions. For instance, impaired tRNA maturation might cause protein synthesis to become less efficient or inaccurate, which could contribute to the development of diseases or disorders associated with protein misfolding or aggregation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
As an inhibitor of DNA-binding transcription factors, Mithramycin A can indirectly influence gene expression, potentially impacting ELAC1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This antibiotic binds to DNA and inhibits RNA synthesis, potentially affecting ELAC1's role in tRNA processing. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A chemotherapy agent that interferes with RNA processing and could indirectly influence ELAC1 activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
As an inhibitor of dihydrofolate reductase, Methotrexate can affect nucleotide synthesis and RNA processing, potentially impacting ELAC1. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, which could lead to altered RNA processing demands and indirectly affect ELAC1. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
An antibiotic that inhibits protein synthesis, potentially impacting RNA processing and ELAC1 activity. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export, which could indirectly affect RNA processing and ELAC1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that affects many cellular processes, potentially influencing ELAC1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects various cellular pathways, potentially influencing RNA processing and ELAC1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to affect numerous signaling pathways, Curcumin could indirectly modulate ELAC1 function or expression. | ||||||